Edwards Lifesciences (EW) Cash from Investing Activities (2009 - 2026)
Edwards Lifesciences (EW) posted quarterly Cash from Investing Activities of -$92.8 million for Q1 2026, down 208.79% year-over-year from $85.3 million in Q1 2025, and up 53.2% quarter-over-quarter from -$198.3 million in Q4 2025.
Edwards Lifesciences (EW) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Edwards Lifesciences' Cash from Investing Activities history runs 18 years deep, the most recent figure standing at -$92.8 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 208.79% year-over-year to -$92.8 million; the TTM figure through Mar 2026 stood at -$891.0 million (down 138.16% YoY), while the FY2025 annual figure was -$712.9 million, down 130.82% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$92.8 million, up from -$198.3 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $2.7 billion in Q3 2024, with the low at -$576.7 million in Q4 2024.
- The 5-year median for Cash from Investing Activities is $63.1 million (2024), against an average of $113.7 million.
- Peak annual rise in Cash from Investing Activities reached 12520.0% in 2024, while the deepest fall reached 4190.07% in 2024.
- Edwards Lifesciences' Cash from Investing Activities stood at $94.7 million in 2022, then slumped by 85.11% to $14.1 million in 2023, then plunged by 4190.07% to -$576.7 million in 2024, then jumped by 65.61% to -$198.3 million in 2025, then jumped by 53.2% to -$92.8 million in 2026.
- Business Quant data shows EW's Cash from Investing Activities at -$92.8 million in Q1 2026, -$198.3 million in Q4 2025, and -$427.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.71 Bn | 194.11 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 127.04 Bn | 123.56 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.81 Bn | 109.59 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 73.18 Bn | 72.64 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 52.03 Bn | 47.78 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.78 Bn | 31.67 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.03 Bn | 22.54 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Zimmer Biomet Holdings | 19.18 Bn | 18.77 Bn | 1.54 Bn | -190.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -193.20 Mn |
| Jun 30, 2026 | -193.20 Mn |
| Mar 31, 2026 | -92.80 Mn |
| Mar 31, 2026 | -92.80 Mn |
| Dec 31, 2025 | -198.30 Mn |
| Dec 31, 2025 | -198.30 Mn |
| Sep 30, 2025 | -427.80 Mn |
| Sep 30, 2025 | -427.80 Mn |
| Jun 30, 2025 | -172.10 Mn |
| Jun 30, 2025 | -172.10 Mn |
| Mar 31, 2025 | 85.30 Mn |
| Mar 31, 2025 | 85.30 Mn |
| Dec 31, 2024 | -576.70 Mn |
| Dec 31, 2024 | -576.70 Mn |
| Sep 30, 2024 | 2.70 Bn |
| Sep 30, 2024 | 2.70 Bn |
| Jun 30, 2024 | 124.80 Mn |
| Jun 30, 2024 | 124.80 Mn |
| Mar 31, 2024 | 63.10 Mn |
| Mar 31, 2024 | 63.10 Mn |